Three patients undergoing renal transplantation were receiving treatment with anakinra in the peri-operative and post-operative period for underlying IL-1-driven autoinflammatory diseases (AOSD, CAPS, and FMF, respectively). This evidence concerns the gene IL1B and familial Mediterranean fever.